Ma, Jin J. Chadban, Steven Y. Zhao, Cathy Chen, Xiaochen Kwan, Tony Panchapakesan, Usha Pollock, Carol A. Wu, Huiling WT and TLR4<sup>−/−</sup> mice treated with streptozotocin display a similar profile of hyperglycemia (A) and changes in body weight (B) over a 24 week period including week 6 (WT n = 12; TLR4<sup>−/−</sup> n = 9), week 12 (WT n = 10; TLR4<sup>−/−</sup> n = 13), week 24 (WT n = 12; TLR4<sup>−/−</sup> n = 12) for diabetes groups and non-diabetes controls were 5 mice per group. <p>The data are present as the means ± SD.</p> cell biology;Signal transduction;cell signaling;Membrane receptor signaling;Immune receptor signaling;Immunological signaling;Molecular cell biology;Metabolic disorders;Diabetes mellitus;Type 1 diabetes;type 2 diabetes;Nephrology;Chronic kidney disease;Model organisms;Animal models;Mouse models;mice;treated;streptozotocin;hyperglycemia;24;12;groups;non-diabetes;controls 2014-05-19
    https://plos.figshare.com/articles/figure/_WT_and_TLR4_8722_8722_mice_treated_with_streptozotocin_display_a_similar_profile_of_hyperglycemia_A_and_changes_in_body_weight_B_over_a_24_week_period_including_week_6_WT_n_8202_8202_12_TLR4_8722_8722_n_8202_8202_9_week_12_WT_n_8202_8202_10_TLR4_8722_872/1031186
10.1371/journal.pone.0097985.g001